Department of Anesthesiology, University Medical Center Hamburg-Eppendorf
Hamburg, 20246, Germany
NCT Number: NCT04168268
To assess self-reported cognitive function and health-related quality of life in patients with and without early postoperative delirium
Looking for future studies?
Notify Me60 year and older
Male
Observational
Hamburg, 20246, Germany
Neurocognitive disorders including postoperative delirium are a serious complication after surgery and anesthesia in the elderly. Postoperative delirium is an acute-onset diffuse brain dysfunction that is characterized by a fluctuating course of confusion, disorganized thinking, inattention, irritability, disturbances of the circadian rhythm, and disorders of consciousness. Post-anesthesia care unit (PACU) delirium occurs immediately after emergence from anesthesia and affects up to 45% of patients after elective surgery.
It is unclear, whether PACU delirium is associated with intermediated or long-term adverse outcomes including neurocognitive disorders or mortality. The aim of this prospective observational was to assess self-reported cognitive function and health-related quality of life in patients with and without PACU delirium three months after radical prostatectomy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: three months
Cognitive Failures Questionnaire
Time frame: three months
Short Form Health Survey 36
Universitätsklinikum Hamburg-Eppendorf
Other
Influence of Post-anesthesia Care Unit Delirium After Radical Prostatectomy on Self-reported Cognitive Function and Health-related Quality of Life
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05929703
Aging, Alzheimer Disease
Orange, California, United States
View Trial DetailsNCT04289142
Analgesics, Analgesics, Non-Narcotic
Vancouver, British Columbia, Canada
View Trial DetailsNCT04007523
Cognition Disorders, Cognitive Dysfunction
Ann Arbor, Michigan, United States
View Trial DetailsNCT03724201
Confusion, Delirium
Calgary, Alberta, Canada
View Trial Details